Published in Cancer on February 01, 1978
Pathogenicity of Bacteria Contaminating Blood Products. Transfus Med Hemother (2011) 0.82
Concurrent M. tuberculosis, Klebsiella pneumoniae, and Candida albicans infection in liver metastasis of bowel carcinoma. Eur J Clin Microbiol Infect Dis (2008) 0.81
Salmonella typhi liver abscess overlying a metastatic melanoma. Am J Trop Med Hyg (2014) 0.81
The Evolving Nature of Hepatic Abscess: A Review. J Clin Transl Hepatol (2016) 0.75
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Hypersensitivity reactions from taxol. J Clin Oncol (1990) 3.83
Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res (1988) 1.84
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol (1993) 1.76
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms. Cancer (1984) 1.71
Cutaneous involvement in malignant histiocytosis. Case report and review of the literature. Arch Dermatol (1981) 1.64
Blood sugar and insulin response of humans in shock. Ann Surg (1970) 1.58
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol (1993) 1.50
Clinical features and natural history of intramedullary spinal cord metastasis. Cancer (1985) 1.43
Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole. Clin Cancer Res (2000) 1.40
Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res (2001) 1.35
Incidence and timing of hypothermia in trauma patients undergoing operations. J Trauma (1991) 1.28
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res (1999) 1.27
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology (1997) 1.24
Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res (1997) 1.20
Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem (2001) 1.19
Importance of continued testicular suppression in hormone-refractory prostate cancer. J Clin Oncol (1993) 1.18
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol (1992) 1.15
Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism (2001) 1.15
Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res (2001) 1.15
Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat Rep (1985) 1.15
The Microbial ecology of the upper small bowel. Am J Gastroenterol (1976) 1.14
Acquired extrinsic pulmonic stenosis caused by mediastinal tumors. Cancer (1982) 1.13
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin Cancer Res (1999) 1.12
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res (2001) 1.09
Factors influencing options in primary breast cancer treatment. J Clin Oncol (1987) 1.07
Hypercalcemia and neuroendocrine carcinoma of the prostate: a report of three cases and a review of the literature. J Clin Oncol (1992) 1.05
A phase II study of taxol in patients with malignant melanoma. Invest New Drugs (1991) 1.04
Bromide intoxication. Johns Hopkins Med J (1976) 1.04
The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. J Clin Endocrinol Metab (1982) 1.01
Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment. Urol Clin North Am (1992) 1.00
Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer. Urol Oncol (2011) 0.99
Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. J Urol (2001) 0.98
Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst (1998) 0.97
Spinal cord compression in prostate cancer. J Neurooncol (1995) 0.97
Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography. Am J Med (1982) 0.95
Choice of starting dose and escalation for phase I studies of antitumor agents. Cancer Chemother Pharmacol (1992) 0.94
Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. Cancer (1982) 0.94
Colonoscopy associated bacteremia. Surg Gynecol Obstet (1976) 0.93
Metastatic Leydig cell tumor of the testis. Report of three cases and review of the literature. Cancer (1986) 0.93
'Sarcoidosis' and sarcoid-like lesions. Their occurrence after cytotoxic and radiation therapy of testis cancer. Arch Intern Med (1981) 0.93
Glutathione and glutathione S-transferase in benign and malignant prostate cell lines and prostate tissues. Biochem Pharmacol (1996) 0.91
Phase I study of taxol administered as a short i.v. infusion daily for 5 days. Cancer Treat Rep (1987) 0.89
Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase. Clin Cancer Res (1996) 0.89
Gynecomastia in men following antineoplastic therapy. Arch Intern Med (1982) 0.88
Growth hormone and adrenal cortical response to shock and trauma in the human. Ann Surg (1971) 0.88
Serious hyponatremia in patients with cancer: management with demeclocycline. Cancer (1981) 0.88
Important clinical pharmacologic considerations in the use of methadone in cancer patients. Cancer Treat Rep (1979) 0.88
Discordance between plasma calcitonin and tumor-cell mass in medullary thyroid carcinoma. N Engl J Med (1979) 0.86
CSF infections complicating the management of neoplastic meningitis. Clinical features and results of therapy. Arch Intern Med (1982) 0.86
Diagnostic laparoscopy as an adjunct to selective conservative management of solid organ injuries after blunt abdominal trauma. J Trauma (1993) 0.86
A phase II trial of CI-958 in patients with hormone-refractory prostate cancer. Cancer Chemother Pharmacol (1999) 0.86
Ectopic adrenocorticotrophic (ACTH) syndrome and small cell carcinoma of the lung-assessment of clinical implications in patients on combination chemotherapy. Cancer (1981) 0.84
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial. Cancer Res (1992) 0.84
Comparison of live bacteria infusions in a porcine model of acute respiratory failure. J Surg Res (1983) 0.84
Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials. Cancer Epidemiol Biomarkers Prev (1996) 0.84
Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion. Cancer (1986) 0.84
Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion. J Clin Oncol (1987) 0.84
Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines. Biochem Pharmacol (1985) 0.82
Effect of positive end-expiratory pressure on extravascular lung water in porcine acute respiratory failure. Crit Care Med (1988) 0.82
Inadvertent administration of 480 mg/m2 of cisplatin. Am J Med (1989) 0.82
Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans. Cancer Res (1989) 0.82
Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer. J Clin Oncol (1987) 0.81
Docetaxel-induced Meibomian duct inflammation and blockage leading to chalazion formation. Prostate Cancer Prostatic Dis (2007) 0.81
Compact anaerobic glove box for hospitals and research laboratories. J Clin Microbiol (1979) 0.81
Acid-base disturbances in hemorrhagic shock. In 66 severely wounded patients prior to treatment. Arch Surg (1969) 0.81
Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. A report of five cases and review of the literature. Am J Med (1980) 0.81
Population pharmacokinetics of hydroxyurea in cancer patients. Cancer Chemother Pharmacol (1995) 0.81
Vitamin D in the prevention and treatment of prostate cancer. Semin Urol Oncol (1999) 0.81
All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes. Cancer Chemother Pharmacol (1998) 0.81
Phase I clinical study with pharmacokinetic analysis of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193) administered as a five-day infusion. Cancer Res (1985) 0.80
Blood gas determinations in the severely wounded in hemorrhagic shock. Arch Surg (1969) 0.80
TNF-alpha protects dendritic cells from prostate cancer-induced apoptosis. Prostate Cancer Prostatic Dis (2001) 0.80
Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors. J Clin Oncol (1994) 0.80
Management of primary germ cell tumors of the mediastinum. J Thorac Cardiovasc Surg (1982) 0.80
Electrolyte solutions in resuscitation in human hemorrhagic shock. Surg Gynecol Obstet (1971) 0.80
Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508. Cancer Res (1994) 0.80
Phase II trial of etoposide in advanced prostate cancer. Cancer Treat Rep (1984) 0.79
Early postlaparotomy percutaneous endoscopic gastrostomy. Surg Gynecol Obstet (1992) 0.79
A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancer. Invest New Drugs (1996) 0.79
A phase I study of SR-2508 and cyclophosphamide administered by intravenous injection. Cancer Res (1991) 0.79
Ectopic hormone syndromes. Cancer Invest (1986) 0.79
Complications of hepatic arterial infusion chemotherapy. Radiographics (1991) 0.79
The value of duodenal bile examination in the evaluation of persistent pain in the upper part of the abdomen. Surg Gynecol Obstet (1978) 0.79
Pharmacokinetic and biotransformation studies of ormaplatin in conjunction with a phase I clinical trial. Cancer Chemother Pharmacol (1994) 0.78
Frequency of abnormalities of cortisol secretion and water metabolism in patients with small cell carcinoma of the lung and other malignancies. Chest (1982) 0.78
Phase II trial of carboplatin in soft-tissue sarcoma. Am J Clin Oncol (1990) 0.78
A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol (2013) 0.78
Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion. Cancer Res (1990) 0.78
The effects of L-dopa on in vitro and in vivo calcitonin release from medullary thyroid carcinoma. J Clin Endocrinol Metab (1979) 0.78
Etoposide and very high dose cisplatin: salvage therapy for patients with advanced germ cell neoplasms. Cancer Treat Rep (1985) 0.78
Ibuprofen plus prostaglandin E1 in a septic porcine model of adult respiratory distress syndrome. J Trauma (1989) 0.77
Psychological distress among women with breast problems. Cancer (1986) 0.77
Psychological and mood disturbance associated with the diagnosis and treatment of testis cancer and other malignancies. J Clin Psychol (1990) 0.77
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study. Clin Cancer Res (1997) 0.77
Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885. Invest New Drugs (1994) 0.77
A phase I trial of high-dose oral tamoxifen and CHOPE. Cancer Chemother Pharmacol (1995) 0.77
Effects of ibuprofen on a porcine model of acute respiratory failure. J Surg Res (1984) 0.77